MarketPeel
Insider Trading Intelligence
LL

Louis G. Lange

BOLD
DIRECTOR · BOUNDLESS BIO, INC. · CIK 0001238401
FILING MIX · LIFETIME43%/57%
BUYS
12
SELLS
16
TOTAL VALUE
$21.72M
COMPANIES
2
ACTIVE SINCE
Jan 2020
HOLDINGS NOW
10,806
AVG SELL PX
$54.38
TRADE KIND
SHOWING 28 / 28
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
4 backtested trades · 8 horizons · 9 pending
Forward-return performance of every backtestable P/S trade by Louis G. Lange, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d4+100.00%-2.68%-1.34%-1.34%-3.27%
14d4+100.00%+3.98%-1.68%+5.65%+1.80%
30d4+25.00%+11.42%+0.79%+10.63%+10.41%
60d4+25.00%+12.76%+7.50%+5.26%+5.88%
90d4+75.00%+1.70%+8.12%-8.62%-10.57%
180d4(3 pending)+0.00%-14.80%+8.62%-23.42%-23.42%
1y4(3 pending)+0.00%-3.15%+23.68%-26.83%-26.83%
2y4(3 pending)+100.00%+74.30%+40.08%+34.23%+34.23%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
BOLD · 0 shares · as of Jan 15, 2020
00000SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 12 buys / 16 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
NAMS
NEWAMSTERDAM PHARMA CO N.V.
SALE
446$31.23$13.9K10,360Mar 11, 2026Mar 12, 2026View →
NAMS
NEWAMSTERDAM PHARMA CO N.V.
SALE
44,173$30.41$1.34M10,806Mar 11, 2026Mar 12, 2026View →
NAMS
NEWAMSTERDAM PHARMA CO N.V.
PURCHASE
44,619$11.50$513.1K54,979Mar 9, 2026Mar 10, 2026View →
NAMS
NEWAMSTERDAM PHARMA CO N.V.
SALE
44,6190Mar 9, 2026Mar 10, 2026View →
NAMS
NEWAMSTERDAM PHARMA CO N.V.
SALE
28,186$29.41$829.0K0Mar 6, 2026Mar 10, 2026View →
NAMS
NEWAMSTERDAM PHARMA CO N.V.
PURCHASEGRANT
Stock grant
15,30015,300Jan 7, 2026Jan 9, 2026View →
NAMS
NEWAMSTERDAM PHARMA CO N.V.
PURCHASEGRANT
Stock grant
3,40010,360Jan 7, 2026Jan 9, 2026View →
NAMS
NEWAMSTERDAM PHARMA CO N.V.
PURCHASE
6828,186Jun 1, 2025Jun 3, 2025View →
NAMS
NEWAMSTERDAM PHARMA CO N.V.
SALE
680Jun 1, 2025Jun 3, 2025View →
NAMS
NEWAMSTERDAM PHARMA CO N.V.
SALE
6968May 1, 2025May 2, 2025View →
NAMS
NEWAMSTERDAM PHARMA CO N.V.
PURCHASE
6928,118May 1, 2025May 2, 2025View →
NAMS
NEWAMSTERDAM PHARMA CO N.V.
SALE
69137Apr 14, 2025Apr 21, 2025View →
NAMS
NEWAMSTERDAM PHARMA CO N.V.
PURCHASE
6928,049Apr 14, 2025Apr 21, 2025View →
NAMS
NEWAMSTERDAM PHARMA CO N.V.
PURCHASEGRANT
Stock grant
3,3083,308Mar 26, 2025Mar 28, 2025View →
NAMS
NEWAMSTERDAM PHARMA CO N.V.
PURCHASE
3,10210,062Mar 26, 2025Mar 28, 2025View →
NAMS
NEWAMSTERDAM PHARMA CO N.V.
SALE
3,102206Mar 26, 2025Mar 28, 2025View →
NAMS
NEWAMSTERDAM PHARMA CO N.V.
PURCHASEGRANT
Stock grant
6,9606,960Jan 7, 2025Jan 8, 2025View →
NAMS
NEWAMSTERDAM PHARMA CO N.V.
PURCHASEGRANT
Stock grant
32,50032,500Jan 6, 2025Jan 8, 2025View →
NAMS
NEWAMSTERDAM PHARMA CO N.V.
PURCHASE
5,000$19.00$95.0K24,878Feb 13, 2024Feb 21, 2024View →
NAMS
NEWAMSTERDAM PHARMA CO N.V.
PURCHASEGRANT
Stock grant
10,00010,000Jan 1, 2024Jan 3, 2024View →
BOLD
BOUNDLESS BIO, INC.
SALE
265,799$60.00$15.95M0Jan 15, 2020Jan 15, 2020View →
BOLD
BOUNDLESS BIO, INC.
SALE
3,555$60.00$213.3K0Jan 15, 2020Jan 15, 2020View →
BOLD
BOUNDLESS BIO, INC.
SALE
13,678$60.00$820.7K0Jan 15, 2020Jan 15, 2020View →
BOLD
BOUNDLESS BIO, INC.
SALE
32,343$60.00$1.94M0Jan 15, 2020Jan 15, 2020View →
BOLD
BOUNDLESS BIO, INC.
SALE
10,0000Jan 15, 2020Jan 15, 2020View →
BOLD
BOUNDLESS BIO, INC.
SALE
18,0000Jan 15, 2020Jan 15, 2020View →
BOLD
BOUNDLESS BIO, INC.
SALE
9,0000Jan 15, 2020Jan 15, 2020View →
BOLD
BOUNDLESS BIO, INC.
SALE
16,2000Jan 15, 2020Jan 15, 2020View →
Other insiders · BOLD
Loading peer insiders…
About this filer
CIK 0001238401
ROLE
Director
PRIMARY
BOLD
COMPANIES
2
ACTIVE SINCE
Jan 2020
MARKETPEEL · /INSIDER/0001238401DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback